Wattel E - Search Results

1

A phase I/II trial of Erlotinib in higher risk myelodysplastic syndromes and acute myeloid leukemia after azacitidine failure.

Thepot S, Boehrer S, Seegers V, Prebet T, Beyne-Rauzy O, Wattel E, Delaunay J, Raffoux E, Hunault M, Jourdan E, Chermat F, Sebert M, Kroemer G, Fenaux P, Adès L; Groupe Francophone des Myelodysplasies (GFM). Thepot S, et al. Among authors: wattel e. Leuk Res. 2014 Dec;38(12):1430-4. doi: 10.1016/j.leukres.2014.09.014. Epub 2014 Oct 7. Leuk Res. 2014. PMID: 25449687 Clinical Trial.

2

Expression of the multidrug resistance P glycoprotein in newly diagnosed adult acute lymphoblastic leukemia: absence of correlation with response to treatment.

Wattel E, Lepelley P, Merlat A, Sartiaux C, Bauters F, Jouet JP, Fenaux P. Wattel E, et al. Leukemia. 1995 Nov;9(11):1870-4. Leukemia. 1995. PMID: 7475277

3

Association of myelodysplastic syndrome and relapsing polychondritis: further evidence.

Hebbar M, Brouillard M, Wattel E, Decoulx M, Hatron PY, Devulder B, Fenaux P. Hebbar M, et al. Among authors: wattel e. Leukemia. 1995 Apr;9(4):731-3. Leukemia. 1995. PMID: 7723411 Review.

4

Inactivation of the p53 gene in leukemias and myelodysplastic syndrome (MDS) with 17p monosomy.

Preudhomme C, Vanrumbeke M, Lai JL, Lepelley P, Wattel E, Fenaux P. Preudhomme C, et al. Among authors: wattel e. Leukemia. 1994 Dec;8(12):2241-2. Leukemia. 1994. PMID: 7808014 No abstract available.

5

p16 gene homozygous deletions in acute lymphoblastic leukemia.

Quesnel B, Preudhomme C, Philippe N, Vanrumbeke M, Dervite I, Lai JL, Bauters F, Wattel E, Fenaux P. Quesnel B, et al. Among authors: wattel e. Blood. 1995 Feb 1;85(3):657-63. Blood. 1995. PMID: 7833469 Free article.

6

Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations.

Lai JL, Preudhomme C, Zandecki M, Flactif M, Vanrumbeke M, Lepelley P, Wattel E, Fenaux P. Lai JL, et al. Among authors: wattel e. Leukemia. 1995 Mar;9(3):370-81. Leukemia. 1995. PMID: 7885035

7

Androgen therapy in myelodysplastic syndromes with thrombocytopenia: a report on 20 cases.

Wattel E, Cambier N, Caulier MT, Sautière D, Bauters F, Fenaux P. Wattel E, et al. Br J Haematol. 1994 May;87(1):205-8. doi: 10.1111/j.1365-2141.1994.tb04895.x. Br J Haematol. 1994. PMID: 7947249 Clinical Trial.

8

p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies.

Wattel E, Preudhomme C, Hecquet B, Vanrumbeke M, Quesnel B, Dervite I, Morel P, Fenaux P. Wattel E, et al. Blood. 1994 Nov 1;84(9):3148-57. Blood. 1994. PMID: 7949187 Free article.

9

Inv(16) may be one of the only 'favorable' factors in acute myeloid leukemia: a report on 19 cases with prolonged follow-up.

Plantier I, Lai JL, Wattel E, Bauters F, Fenaux P. Plantier I, et al. Among authors: wattel e. Leuk Res. 1994 Dec;18(12):885-8. doi: 10.1016/0145-2126(94)90098-1. Leuk Res. 1994. PMID: 7996869 Clinical Trial.

10

A randomized trial comparing vinblastine in slow infusion and by bolus i.v. injection in idiopathic thrombocytopenic purpura: a report on 42 patients.

Facon T, Caulier MT, Wattel E, Jouet JP, Bauters F, Fenaux P. Facon T, et al. Among authors: wattel e. Br J Haematol. 1994 Mar;86(3):678-80. doi: 10.1111/j.1365-2141.1994.tb04810.x. Br J Haematol. 1994. PMID: 8043455 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

190 results

Search Page